Satter Muneer A

Director | Director, 10% Owner | See Remarks +2 more

5 companies

Good

Trades Analyzed

12M Win Rate

33.3%

Avg 3M Return

+35.7%

Avg 12M Return

-3.5%

Satter Muneer A is a See Remarks at Rein Therapeutics, Inc. with holdings across 5 companies. Recent SEC Form 4 filings include 17 buys and 0 sells.

Estimated insider holdings value: $101.8M based on current market prices.

Holdings by Company

RNTXJan 8, 2021

Current Shares16.61M

Value$19.93M

Net Activity+12.73M

Bought: 12.73MSold: 0

ANNXNov 21, 2025

Current Shares9.73M

Value$55.99M

Net Activity+7.97M

Bought: 7.97MSold: 0

WHWKJan 10, 2019

Current Shares5.62M

Value$22.37M

Net Activity+3.50M

Bought: 3.50MSold: 0

AKBAJul 5, 2017

Current Shares3.04M

Value$3.52M

Net Activity+1.45M

Bought: 1.45MSold: 0

IMUXSep 17, 2018

Current Shares0

Value-

Net Activity-6,732,277

Bought: 4.65MSold: 11.38M

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 21, 2025	ANNX Annexon, Inc.	Director	Buy	822,613	$4.38	$3,600,783.64	+4.5%	+19.4%	-
Nov 19, 2025	ANNX Annexon, Inc.	Director	Buy	1,500,000	$3.37	$5,055,000.00	+6.3%	+24.1%	-
Dec 26, 2023	ANNX Annexon, Inc.	Director, 10% Owner	Buy	350,000	$2.88	$1,008,000.00	+5.0%	+50.6%	+19.3%
Feb 10, 2023	ANNX Annexon, Inc.	Director, 10% Owner	Buy	2,647,058	$6.80	$17,999,994.40	+60.0%	-17.5%	-18.4%
Jul 7, 2022	ANNX Annexon, Inc.	Director	Buy	2,453,988	$3.84	$9,423,313.92	+125.5%	+66.5%	-11.3%
Jan 8, 2021	RNTX Rein Therapeutics, Inc.	See Remarks	Buy	9,000,000	$1.10	$9,900,000.00	+118.3%	-	-
Jul 28, 2020	ANNX Annexon, Inc.	Director	Buy	200,000	$17.00	$3,400,000.00	+11.4%	-	-
Jun 8, 2020	RNTX Rein Therapeutics, Inc.	Director, 10% Owner, See Remarks	Buy	3,700,000	$1.10	$4,070,000.00	+94.6%	-	-
Jan 10, 2019	WHWK Whitehawk Therapeutics, Inc.	Director, 10% Owner	Buy	63,818	$2.35	$150,290.23	+0.4%	-	-
Jan 7, 2019	WHWK Whitehawk Therapeutics, Inc.	Director, 10% Owner	Buy	60,000	$2.12	$127,462.00	+0.4%	-	-